Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...
321,566 Children Lost a Parent to Drug Overdose in 2011 to 2021
From 2011 to 2021, an estimated 321,566 children lost a parent to drug overdose in the United States, according to a study published online May 8 in JAMA...
Majority of U.S. Adults Give Health Care System a 'D' for Handling Mental Health
Three-quarters of U.S. adults believe mental health issues are identified and treated worse than physical health issues, according to the results of a...
Distal Symmetric Polyneuropathy Often Undiagnosed
Distal symmetric polyneuropathy (DSP) is common and is frequently undiagnosed, according to a study published online May 8 in Neurology.Melissa A. Elafros,...
Procedure Risk Tied to Outcomes in Older Emergency General Surgery Patients
Procedure risk is more strongly associated with outcomes in older patients undergoing emergency general surgery than assessing frailty, according to a...
Dogs Brought to U.S. Must Be Microchipped, Older Than 6 Months: CDC
Dogs brought into the United States from abroad must be compliant with new rules to help fight rabies in this country, according to updated guidance from...
More Than 321,000 U.S. Kids Lost a Parent to Drug ODs in a Decade
More than 320,000 U.S. children lost a parent to drug overdose during the past decade, according to a new study reported May 8 in JAMA Psychiatry. What’s...
About 90% of U.S. Adults Are On the Way to Heart Disease
Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the...
There's a New Set of COVID Variants Called FLiRT: What You Need to Know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...
Bayer to Unveil Late-Breaking Data from Phase III OASIS 1 and 2 for Elinzanetant in the Treatment of Vasomotor Symptoms Associated with Menopause
Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound...
Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effective
Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more...
An Orangutan Healed Himself With Medicinal Plant
Primates are capable of tending to wounds using medicinal plants, a new case report says. A male Sumatran orangutan treated a facial wound with a climbing...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...